These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 32265915)
1. Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications. Lia G; Di Vito C; Cerrano M; Brunello L; Calcaterra F; Tapparo M; Giaccone L; Mavilio D; Bruno B Front Immunol; 2020; 11():422. PubMed ID: 32265915 [TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation. Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431 [TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies. Zaghi E; Calvi M; Di Vito C; Mavilio D Front Immunol; 2019; 10():2794. PubMed ID: 31849972 [TBL] [Abstract][Full Text] [Related]
7. Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation. Ito A; Kitano S; Tajima K; Kim Y; Tanaka T; Inamoto Y; Kim SW; Yamamoto N; Fukuda T; Okamoto S Int J Hematol; 2020 Jan; 111(1):120-130. PubMed ID: 31641956 [TBL] [Abstract][Full Text] [Related]
8. How important is NK alloreactivity and KIR in allogeneic transplantation? Shaffer BC; Hsu KC Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259 [TBL] [Abstract][Full Text] [Related]
9. The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation. Köhler N; Ruess DA; Kesselring R; Zeiser R Front Immunol; 2021; 12():634435. PubMed ID: 33746972 [TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in allogeneic hematopoietic stem cell transplantation: From the lab to the clinic. Gu G; Yang JZ; Zhang JQ; Sun LX Cell Immunol; 2019 Dec; 346():103991. PubMed ID: 31607390 [TBL] [Abstract][Full Text] [Related]
12. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H Front Immunol; 2019; 10():1997. PubMed ID: 31507601 [TBL] [Abstract][Full Text] [Related]
13. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations. Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062 [TBL] [Abstract][Full Text] [Related]
14. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173 [TBL] [Abstract][Full Text] [Related]
15. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function. Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN Front Immunol; 2018; 9():2538. PubMed ID: 30473695 [TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation. Cheng AP; Cheng MP; Loy CJ; Lenz JS; Chen K; Smalling S; Burnham P; Timblin KM; Orejas JL; Silverman E; Polak P; Marty FM; Ritz J; De Vlaminck I Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058359 [No Abstract] [Full Text] [Related]
18. Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature. Gupta M; Tieu A; Slobodian M; Shorr R; Burger D; Lalu MM; Allan DS Stem Cell Rev Rep; 2021 Apr; 17(2):332-340. PubMed ID: 33159616 [TBL] [Abstract][Full Text] [Related]
19. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease. Chang YJ; Zhao XY; Huang XJ Front Immunol; 2018; 9():3041. PubMed ID: 30619371 [TBL] [Abstract][Full Text] [Related]